MedTrace Logo

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

NCT04426643 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-05-25

No results posted yet for this study

Summary

Treatment of patients with urinary incontinence after prostatectomy using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Conditions

Interventions

BIOLOGICAL

Autologous adipose-derived mesenchymal stem cells

Autologous adipose-derived mesenchymal stem cells mixed with collagen solution injected in submucosal space

OTHER

Standard treatment according to the Clinical protocols

Standard treatment according to the Clinical protocols

Sponsors & Collaborators

  • N.N. Alexandrov National Cancer Centre

    collaborator OTHER_GOV

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Igor D Volotovski, Dr · Head of the Lab of Institute of Biophysics and Cell Engineering

  • Sergey A Krasny, Dr · Deputy Director for Research of the National Cancer Centre

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-02-20
Completion
2021-03-31

Countries

  • Belarus

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04426643 on ClinicalTrials.gov